Kindeva Drug Delivery and Orbia Fluorinated Solutions (Koura) Announce Collaboration for Low GWP Propellant Conversion

Contributed by: Business Wire

Logo

Tags

Other Manufacturing

Medical Devices

Medical Supplies

Chemicals/Plastics

Manufacturing

Other Health

Health

Pharmaceutical

General Health

Kindeva Drug Delivery

More Like This

Orbia Fluor & Energy Materials Advances Project to Increase Production of Zephex® 152a in UK

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

Kindeva Drug Delivery Expands Loughborough, UK, Facilities at Charnwood Campus to Support Growth of Green Propellant Commercialization

Kindeva Drug Delivery Launches New Analytical Services Global Business Unit

Orbia Fluor & Energy Materials (Koura) Launches New Low-GWP Alternative to R-1234yf for the EU and UK Automotive Aftermarket

Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development and Manufacturing Organization

Orbia Releases Annual Impact Report, Highlighting Strong Progress on Sustainability-Driven Agenda

Orbia Receives Award for Property Risk Management from FM